Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept vs Infliximab in RA (ATTEST)
NCT00095147Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2005
- Primary completion
- Jul 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 17
01
Overview
A Phase 3 trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Feb 2005; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00095147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095147.